We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
(-2.8%)
Cap. Flow
-$952M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 2 |
Prologis
PLD
|
+$150M |
| 3 |
Chevron
CVX
|
+$109M |
| 4 |
Qualcomm
QCOM
|
+$101M |
| 5 |
Paycom
PAYC
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$230M |
| 2 |
Kimberly-Clark
KMB
|
+$160M |
| 3 |
Stanley Black & Decker
SWK
|
+$130M |
| 4 |
Paychex
PAYX
|
+$113M |
| 5 |
Dominion Energy
D
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Healthcare | 17.11% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
EPR Properties
EPR
$4.37B
| $3.9M | 0.01% |
92,940
+76
| +0.1% | +$3.13K |
|
777
Codexis
CDXS
$147M
| $3.89M | 0.01% |
1,254,465
-97,415
| -7% | -$313K |
|
778
Array Technologies
ARRY
$647M
| $3.83M | 0.01% |
+373,133
| New | +$4.74M |
|
779
Chegg
CHGG
$81.5M
| $3.8M | 0.01% |
1,202,027
-88,749
| -7% | -$441K |
|
780
LPL Financial
LPLA
$26.2B
| $3.79M | 0.01% |
13,585
+2,616
| +24% | +$710K |
|
781
Booking.com
BKNG
$129B
| $3.76M | 0.01% |
23,725
-1,000
| -4% | -$148K |
|
782
NorthWestern Energy
NWE
$4.22B
| $3.76M | 0.01% |
75,032
+27,601
| +58% | +$1.39M |
|
783
Becton Dickinson
BDX
$49.5B
| $3.73M | 0.01% |
15,945
-509
| -3% | -$120K |
|
784
Tesla
TSLA
$1.41T
| $3.67M | 0.01% |
18,561
-805
| -4% | -$141K |
|
|
OPTU
785
Optimum Communications Inc
OPTU
$385M
| $3.66M | 0.01% |
1,796,554
-1,140,796
| -39% | -$2.53M |
|
786
Grindr
GRND
$2.7B
| $3.64M | 0.01% |
+297,391
| New | +$2.97M |
|
787
Digi International
DGII
$2.66B
| $3.63M | 0.01% |
+158,399
| New | +$4.25M |
|
788
HCI Group
HCI
$2.34B
| $3.61M | 0.01% |
39,172
+6,752
| +21% | +$704K |
|
789
CNX Resources
CNX
$4.99B
| $3.58M | 0.01% |
147,197
+100,095
| +213% | +$2.44M |
|
|
TGI
790
DELISTED
Triumph Group
TGI
| $3.56M | 0.01% |
231,239
-3,988
| -2% | -$56.8K |
|
791
EnerSys
ENS
$6.2B
| $3.54M | 0.01% |
34,216
-791
| -2% | -$77.6K |
|
792
Tapestry
TPR
$23.5B
| $3.49M | 0.01% |
81,618
+16,387
| +25% | +$685K |
|
793
Kinetik
KNTK
$4.33B
| $3.47M | 0.01% |
+83,655
| New | +$3.32M |
|
794
D.R. Horton
DHI
$38.7B
| $3.46M | 0.01% |
24,572
-23,261
| -49% | -$3.42M |
|
795
MaxLinear
MXL
$6.3B
| $3.46M | 0.01% |
171,932
-32,258
| -16% | -$634K |
|
796
Marvell Technology
MRVL
$206B
| $3.45M | 0.01% |
49,412
+8,666
| +21% | +$607K |
|
797
UMB Financial
UMBF
$10.2B
| $3.44M | 0.01% |
41,211
+34,560
| +520% | +$2.83M |
|
798
Upwork
UPWK
$1.07B
| $3.43M | 0.01% |
318,659
+1,996
| +0.6% | +$22.6K |
|
799
Enpro
NPO
$6.08B
| $3.4M | 0.01% |
23,353
+150
| +0.6% | +$22.7K |
|
800
Fate Therapeutics
FATE
$292M
| $3.38M | 0.01% |
1,031,505
+24,127
| +2% | +$106K |
|
Similar funds
Federated Hermes's Q2 2024 Portfolio in Review
As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
- Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
- Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
- Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
- Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
- Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
- Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.
Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.